Printer Friendly

Marrow culture aids in cancer prediction.

Marrow culture aids in cancer prediction

Surgeons have no sure means of knowing whether some cancer cells from a breast tumor they have removed may already have spread to a distant site. So, in deciding whether to embark on a course of postsurgical chemotherapy, they must rely upon indirect clues to judge the chances of recurrence, including cancer severity and the presence or absence of estrogen receptors on the tumor cells.

Now researchers say they've developed the first direct test for detecting cancer cells that have spread to bone marrow. Their technique, if validated in further studies, should help identify women at low risk of recurrence and may save some women from unpleasant chemotherapy regimens.

William P. Vaughan, J. Graham Sharp and their colleagues at the University of Nebraska Medical Center in Omaha cultured bone marrow cells taken from 28 women with breast cancer. The women were candidates for an experimental breast cancer therapy involving intensive, whole-body radiation treatments that wipe out hidden cancer cells. Since the treatment also kills marrow cells, surgeons first remove some marrow, then reinfuse it after radiation therapy ends -- a procedure, called autologous marrow transplantation. Using special stains, they scrutinize the extracted marrow for cancer cells. If any appear, the doctor may "purge" the malignant cells with drugs before reinfusing the patient.

The Nebraska researchers plated marrow cells in a culture medium. Within a few weeks they saw cancerous growths in more than half of the specimens that had appeared normal under conventional staining techniques. In follow-up periods ranging from six to 38 months, eight of the 16 culture-positive women suffered relapses. In contrast, only one with a negative culture relapsed, the team reported last week at the annual meeting of the American Society of Clinical Oncology in Washington, D.C.

"It's a very important observation," says oncologist Bruce D. Cheson of the National Cancer Institute in Bethesda, Md. Autologous marrow transplants among breast cancer patients are "going gangbusters," he says, with hundreds performed per year despite a relative shortage of data regarding the technique's ultimate benefits. Physicians would value any test that helps predict cancer outcomes and treatment requirements, Cheson says.

"this is the first technique for actual detection of small numbers of malignant cells at a distant site," Vaughan says. He estimates that the method can detect a single cancer cell in a sample of 10,000 cells -- far better than a pathologist could do looking at a stained slide under a microscope.
COPYRIGHT 1990 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1990, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Author:Weiss, Rick
Publication:Science News
Date:Jun 2, 1990
Words:410
Previous Article:Mapping new features of Milky Way's bulge.
Next Article:Intense winter lightning zaps Gulf Stream.
Topics:


Related Articles
Establishing a link.
Cranking up cancer treatments: a bright future for growth factors.
Drug-resistance gene saves mouse marrow.
Antibodies pinpoint migrating mini-tumors.
Breast cancer therapy's leukemia risks.
Making sense of antisense in cancer.
The mandate for investigational cancer therapies.
Marrow Can Hide Breast Cancer Cells.
Aetna Urges Doctors to Stay With Traditional Cancer Care.
Association of breast cancer and immune thrombocytopenic purpura.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters